COVID-19-Related Thrombosis in Japan: Final Report of a Questionnaire-Based Survey in 2020-Reference-Cited by-同舟云学术

COVID-19-Related Thrombosis in Japan: Final Report of a Questionnaire-Based Survey in 2020

Published:2021-04-01 Issue:4 Volume:28 Page:406-416
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Horiuchi Hisanori¹²³,Morishita Eriko¹²⁴⁵,Urano Tetsumei¹⁶,Yokoyama Kenji¹⁴⁷,

Affiliation:

1. The Japanese Society of Thrombosis and Hemostasis

2. The Japan Atherosclerosis Society

3. Department of Molecular and Cellular Biology, Institute of Development, Aging and Cancer, Tohoku University

4. The Research Study Team for Intractable Disease (Blood Coagulation Abnormalities) supported by the Ministry of Health, Labour and Welfare of Japan

5. Department of Clinical Laboratory Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Faculty of Health Sciences, Kanazawa University

6. Department of Medical Physiology, Hamamatsu University School of Medicine

7. Department of Hematology/Oncology, Tokai University Hachioji Hospital

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/28/4/28_RPT001/_pdf

Reference15 articles.

1. 1) Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers D, Kant KM, Kaptein FHJ, van Paassen J, Stals HAM, Huisman MV, Endeman H: Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis. Thromb Res, 2020; 191: 148-150

2. 2) Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, Clark C, Iba T: ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost, 2020; 18: 1023-1026

3. 3) Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, Zhang Z: D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost, 2020; 18: 1324-1329

4. 4) Ackermann M, Verleden S, Kuehnel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A, Li WW, Li VW, Mentzer SJ, Jonigk D: Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med, 2020; 383: 120-128

5. 5) Hayakawa M, Takano K, Kayashima M, Kasahara K, Fukushima H, Matsumoto M: Management of a COVID-19 Patient during ECMO: Paying Attention to Acquired von Willebrand Syndrome. J Atheroscler Thromb, 2021; 28: 396-401

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unfractionated Heparin Safety in COVID-19: Incidence and Risks of Bleeding Complications in Japan;Journal of Atherosclerosis and Thrombosis;2024-08-01

2. Prevention of Venous Thromboembolism for COVID-19 Patients Based on Clinical Guidance of Prevention of Venous Thromboembolism in COVID-19 (Version 2.0);The Japanese Journal of Phlebology;2024-04-27

3. Platelet and large platelet ratios are useful in predicting severity of COVID-19;International Journal of Hematology;2024-03-23

4. Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 complex as a serum biomarker for COVID-19;Frontiers in Immunology;2024-01-11

5. Characteristics and prognosis of patients with COVID-19 and hematological diseases in Japan: a cross-sectional study;International Journal of Hematology;2024-01-03